Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors
NCT ID: NCT03718546
Last Updated: 2025-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
754 participants
OBSERVATIONAL
2019-04-03
2024-10-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database
NCT01353677
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004994
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
NCT00126477
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
NCT02338479
Cognitive, Academic and Psychosocial Functioning in Long-Term Survivors of Pediatric Stem Cell Transplantation
NCT01701492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sibling pediatric donors
Donors who are donating to a sibling
No interventions assigned to this group
Sibling recipients and caregivers
Recipients who are receiving a transplant from a sibling
No interventions assigned to this group
Non-donor sibling
From the donor-recipient families
No interventions assigned to this group
Non-donor siblings
Of patients receiving unrelated transplants
No interventions assigned to this group
Healthy comparison
A matched sample
No interventions assigned to this group
Parents
Parent/caregiver of study participating donor.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Donor between the age of 5 and 17 who is donating to a sibling
* Parent/caregiver of study participating donor
* Recipient sibling aged 5 to 17 of study participating donor
* Any of the donor's non-donor/non-recipient siblings between 5 and 17
* Any child between 5 and 17 with a brother or sister (also between 5 and 17) receiving a transplant from an unrelated source
* Be willing and able to provide signed informed consent:
* Adults must give consent for their children's and, if applicable, their own participation
* Assent will be obtained in accordance with guidelines at the participant's transplant institution
* Be willing and able to respond to psychological assessment questions
* Must be the donor's first donation
* Recipient must consent to the CIBMTR research database
Exclusion Criteria
* Donor or non-donor siblings who do not live in the same household as the recipient at lease half of the time
* Unable to consent/assent or complete a phone interview in English
* Parents may consent/assent in Spanish
* No access to a telephone
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Center for International Blood and Marrow Transplant Research
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Galen Switzer, Ph.D
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
City of Hope
Duarte, California, United States
Loma Linda University
Loma Linda, California, United States
Children's Hospital of Los Angeles
Los Angeles, California, United States
Rady Children's Hospital San Diego
San Diego, California, United States
University of California San Francisco Medical Center
San Francisco, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Niklaus Children's Hospital
Miami, Florida, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
University of Louisville Hospital - James Brown Cancer Center
Louisville, Kentucky, United States
Children's Hospital of New Orleans/LSUHSC
New Orleans, Louisiana, United States
NIH/NCI
Bethesda, Maryland, United States
University of Michigan
Ann Arbor, Michigan, United States
Spectrum Health
Grand Rapids, Michigan, United States
The Children's Mercy Hospitals and Clinics
Kansas City, Missouri, United States
St. Louis Children's Hospital
St Louis, Missouri, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Westchester Medical Center
New York, New York, United States
University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Children's Health (formerly Children's Medical Center Dallas)
Dallas, Texas, United States
Methodist Healthcare System of San Antonio/Texas Transplant Institute
San Antonio, Texas, United States
University of Utah Blood and Marrow Transplant Program - Pediatrics
Salt Lake City, Utah, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-SIBS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.